Most of the identified genes have not been studied for their role in ALL, emphasising that this approach is likely to generate novel potential target genes, with the exception of IGF2BP1 (ETV6-RUNX1) and WNT16 (TCF3-PBX1). Here, IGF2BP1 is linked to acute lymphoblastic leukemia.